Tusamitamab Ravtansine
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Tusamitamab Ravtansine, covering 2024-03-28 to 2025-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors [Phase 1]